Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
Go back to Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue| Labranche & Co (NASDAQ: LAB) | Delayed: 0.67 +0.02 (3.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.65 | 52 Week High | $4.47 | |||
| Open | $0.66 | 52 Week Low | $3.02 | |||
| Day High | $0.69 | P/E | N/A | |||
| Day Low | $0.66 | EPS | $-1.56 | |||
| Volume | 2,619,343 | |||||

